24 August 2017Asia
Pfizer pneumonia patent approved in blow to MSF
The Indian Patent Office has approved pharmaceutical company Pfizer’s application to patent its Prevenar 13 (pneumococcal 7-valent conjugate) drug, despite claims by Médecins Sans Frontières (MSF) that it is too obvious.
